Potential interests of heart rate lowering drugs

Heart

Volumn 81, Issue 4, 1999, Pages 336-341

  Laperche, T ^a,b   Logeart, D ^a   Cohen Solal, A ^a   Gourgon, R ^a  

^a BEAUJON HOSPITAL   (France)

^b CENTRE CARDIOLOGIQUE DU NORD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACEBUTOLOL; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ZATEBRADINE;

ANTIARRHYTHMIC ACTIVITY; ATHEROSCLEROSIS; CHRONOTROPISM; COMORBIDITY; DISEASE ASSOCIATION; DRUG EFFECT; HEART ARRHYTHMIA; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE OXYGEN CONSUMPTION; HUMAN; HYPERCHOLESTEROLEMIA; PRIORITY JOURNAL; REVIEW; SYSTOLE;

EID: 0032944725     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.81.4.336     Document Type: Review

References (44)

1. Kannel WB, Kannel C, Paffenbarger RS, et al. Heart rate and cardiovascular mortality: the Framingham study. Am Heart J 1987;113:1489-94.
2. Shaper AG, Wannamethee G, Macfarlane PW, et al. Heart rate, ischaemic heart disease, and sudden cardiac death in middle-age British men. Br Heart J 1993;70:49-55.
3. Mensink GBM, Hoffmeister H. The relationship between resting heart rate and all-cause, cardiovascular and cancer mortality. Eur Heart J 1997;18:1404-10.
4. Levine HJ. Rest heart rate and life expectancy. J Am Coll Cardiol 1997;30:1104-6.
5. Mangoni AA, Mircoli L, Giannatassio C, et al. Heart rate dependence of arterial distensibility in vivo. J Hypertens 1996;14:897-901.
6. Sa Cunha R, Pannier B, Benetos A, et al. Association between high heart rate and arterial rigidity in normotensive and hypertensive subjects. J Hypertens 1997;15:1423-30.
7. Beere PA, Glagov S, Zarins CK. Retarding effect of lowered heart rate on coronary atherosclerosis. Science 1984;226:180-2.
8. Beere PA, Glagov S, Zarins CK. Experimental atherosclerosis at the carotid bifurcation of the cynomologus monkey: localization, compensatory enlargement, and the sparing effect of lowered heart rate. Arterioscler Thromb 1992;12:1245-53.
9. Perski A, Olsson G, Landou C, et al. Minimum heart rate and coronary atherosclerosis: independent relations to global severity and rate of progression of angiographic lesions in men with myocardial infarction at a young age. Am Heart J 1992;123:609-16.
10. Ku DN, Giddens DP. Pulsatile flow in a model carotid bifurcation. Arteriosclerosis 1983;3:31-9.
11. Boudoulas H, Rittgers SE, Lewis RP, et al. Changes in diastolic time with various pharmacologic agents: implications for myocardial perfusion. Circulation 1979;60:164-9.
12. Bonaa KH, Arnesen E. Association between heart rate and atherogenic blood lipid fractions in a population: the Tromso study. Circulation 1992;96:394-405.
13. Suga H. Total mechanical energy of a ventricle model and cardiac oxygen consumption. Am J Physiol 1979;236:H498-505.
14. Asanoi H, Sasayama S, Kameyama T. Ventriculoarterial coupling in normal and failing heart in humans. Circulation Res 1989;65:483-93.
15. Prabhu SD, Freeman GL. Left ventricular energetics in closed-chest dogs. Am J Physiol 1993;265:H1048-55.
16. Eichhorn EJ, Heesch CM, Barnett JH, et al. Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: a randomized double-blind, placebo-controlled study. J Am Coll Cardiol 1994;24:1310-20.
17. Yamakawa H, Takeuchi M, Takaoka H, et al. Negative chronotropic effect of β-blockade therapy reduces myocardial oxygen expenditure for non mechanical work. Circulation 1996;94:340-5.
18. Shinke T, Takeuchi M, Takaoka H, et al. Beneficial effect of bradycardia on cardiac energetics in patients with left ventricular dysfunction: beta-blocker vs specific bradycardiac agent [abstract]. Circulation 1997;96:1-644.
19. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996;334:1349-55.
20. Lechat P, Escolano S, Golmard JL, et al. Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the cardiac insufficiency bisoprolol study (CIBIS). Circulation 1997;96:2197-205.
21. Nul DR, Doval HC, Grancelli HO, et al. Heart rate is a marker of amiodarone mortality reduction in severe heart failure. J Am Coll Cardiol 1997;29:1199-205.
22. Mulieri LA, Hasenfuss G, Leavitt B, et al. Altered myocardial force-frequency relation in human heart failure. Circulation 1992;85:1743-50.
23. Ross Jr J, Miura T, Kambayashi M, et al. Adrenergic control of the force-frequency relation. Circulation 1995;92:2327-32.
24. Feldman MD, Alderman JD, Aroesty JM, et al. Depression of systolic and diastolic myocardial reserve during atrial pacing tachycardia in patients with dilated cardiomyopathy. J Clin Invest 1988;82:1661-9.
25. Hasenfuss G, Holubarsch C, Hermann HP, et al. Influence of the force-frequency relationship on haemodynamics and left ventricular function in patients with non-failing hearts and in patients with dilated cardiomyopathy. Eur Heart J 1994;15:164-70.
26. Dougherty AH, Naccarelli GV, Gray EL, et al. Congestive heart failure with normal systolic function. Am J Cardiol 1984;54:778-82.
27. Carroll JD, Hess OM, Hirzel HO, et al. Exercise-induced ischemia: the influence of altered relaxation on early diastolic pressures. Circulation 1983;67:521-8.
28. Miura T, Miyazaki S, Guth BD, et al. Heart rate and force-frequency effects on diastolic function of the left ventricle in exercising dogs. Circulation 1994;89:2361-8.
29. Aroesty JM, McKay RG, Heller GV, et al. Simultaneous assessment of left ventricular systolic and diastolic dysfunction during pacing-induced ischemia. Circulation 1985;71:889-900.
30. Brutsaert DL, Sys SU, Gillebert TC. Diastolic failure: pathophysiology and therapeutic implications. J Am Coll Cardiol 1993;22:318-25.
31. Pozzoli M, Traversi E, Cioffi G, et al. Loading manipulations improve the prognostic value of Doppler evaluation of mitral flow in patients with chronic heart failure. Circulation 1997;95:1222-30.
32. Guth BD, Heusch G, Seitelberger R, et al. Mechanism of beneficial effect of β-adrenergic blockade on exercise-induced myocardial ischemia in conscious dogs. Circ Res 1987;60:738-46.
33. Guth BD, Heusch G, Seitelberger R, et al. Elimination of exercise-induced regional myocardial dysfunction by a bradycardiac agent in dogs with chronic coronary stenosis. Circulation 1987;75:661-9.
34. Frishman WH, Pepine CJ, Weiss R, et al. The addition of a direct sinus node inhibitor (zatebradine) provides no greater exercise tolerance benefit to patients with angina pectoris treated with extended-release nifedipine: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study. J Am Coll Cardiol 1995;26:305-12.
35. Glasser SP, Michie DD, Thadani U, et al. Effects of zatebradine (ULFS 49 CL), a sinus node inhibitor, on heart rate and exercise duration in chronic stable angina pectoris. Am J Cardiol 1997;79:1401-15.
36. Quyyumi AA, Wright CA, Mockus LJ, et al. Mechanisms of nocturnal angina pectoris: importance of increased myocardial oxygen demand in patients with severe coronary artery disease. Lancet 1984;i:1207-9.
37. Panza JA, Diodati JG, Callahan TS, et al. Role of increases in heart rate in determining the occurrence and frequency of myocardial ischemia during daily life in patients with stable coronary artery disease. J Am Coll Cardiol 1992;20:1092-8.
38. The Multicenter Postinfarction Research Group. Risk stratification and survival after myocardial infarction. N Engl J Med 1983;309:331-6.
39. Copie X, Hnatkova K, Staunton A, et al. Predictive power of increased heart rate versus depressed left ventricular ejection fraction and heart rate variability for risk stratification after myocardial infarction. J Am Coll Cardiol 1996;27:270-6.
40. Kiekshus J. Heart rate reduction-a mechanism of benefit? Eur Heart J 1987;8 (suppl L):115-22.
41. Boissel J-P, Leizorovicz A, Piclet H, et al. Secondary prevention after high risk acute myocardial infarction with low-dose acebutolol. Am J Cardiol 1990;66:251-60.
42. Viscoli CM, Horwitz RI, Singer BH. Beta-blockers after myocardial infarction: influence of first-year clinical course on long-term effectiveness. Ann Intern Med 1993;118:99-105.
43. Frishman WH, Gabor R, Pepine C, et al. Heart rate reduction in the treatment of chronic stable angina pectoris: experiences with a sinus node inhibitor. Am Heart J 1996;131:204-10.
44. Dyer AR, Persky V, Stamler J, et al. Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. Am J Epidemiol 1980;112:736-49.